Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (APLT)

CUSIP: 03828A101

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
143,223,667
Total 13F shares
2,395,520
Share change
+199,485
Total reported value
$26,326,659
Price per share
$10.99
Number of holders
29
Value change
+$2,265,568
Number of buys
21
Number of sells
7

Security key

03828A101

Report period

Q3 2019

Institutions

29

Top holders

10

APLT full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2019 Previous quarter: Q2 2019

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top shareholders of APLT - Applied Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
—
13D/G signal
—
Evidence rows
0
Latest as of
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q3 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
29
Shares
2,395,520
Rows loaded
29
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders
13
Q3 2019 holders
29
Holder diff
16
Investor Q2 2019 Shares Q3 2019 Shares Share Diff Share Chg % Q2 2019 value Q3 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .